<code id='A33C0E3983'></code><style id='A33C0E3983'></style>
    • <acronym id='A33C0E3983'></acronym>
      <center id='A33C0E3983'><center id='A33C0E3983'><tfoot id='A33C0E3983'></tfoot></center><abbr id='A33C0E3983'><dir id='A33C0E3983'><tfoot id='A33C0E3983'></tfoot><noframes id='A33C0E3983'>

    • <optgroup id='A33C0E3983'><strike id='A33C0E3983'><sup id='A33C0E3983'></sup></strike><code id='A33C0E3983'></code></optgroup>
        1. <b id='A33C0E3983'><label id='A33C0E3983'><select id='A33C0E3983'><dt id='A33C0E3983'><span id='A33C0E3983'></span></dt></select></label></b><u id='A33C0E3983'></u>
          <i id='A33C0E3983'><strike id='A33C0E3983'><tt id='A33C0E3983'><pre id='A33C0E3983'></pre></tt></strike></i>

          fashion

          fashion

          author:Wikipedia    Page View:49
          Bruce Broussard. -- health business coverage from STAT
          Humana CEO Bruce Broussard Jason DeCrow/AP

          Bruce Broussard, CEO of health insurance giant Humana, will step down next year after leading the company for more than a decade.

          Humana named Jim Rechtin — who is the CEO of Envision Healthcare, the controversial physician staffing firm that is working its way through bankruptcy — as Broussard’s replacement. Rechtin will serve as president and chief operating officer starting Jan. 8 and then take over as CEO in the “latter half of 2024,” the company said in a news release.

          advertisement

          Humana’s stock fell by more than 2% on the news Wednesday morning.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era
          Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

          WhatdoesCovid-19haveinstoreforthewinter?Whenaregooddatanotgoodenough?Andhowmanywould-beWegovysarethe

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          Dramatically reducing cancer deaths requires the PASTEUR Act

          ThesuperbugStaphylcocusepidermidisisshownonanagarplate.Morethan3millionAmericansdevelopadrug-resista